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NC-ND license (http://creativecommoAim: To investigate the prevalence and the characteristics of gastroesophageal reflux disease
(GERD) in infants with apparent life threatening events (ALTE).
Materials and methods: Infants with at least one episode of ALTE in absence of predisposing
factors were included. All infants underwent a cardiorespiratory recording with simultaneous
24-hour pH-monitoring. Patients were divided into 3 groups according to the severity of GERD:
A. Reflux Index (RI) <3%, B. RI Z 3e7%, C. RI >7%. Monthly evaluations were performed and
the anti-reflux therapy was maintained till normalization of monitoring and clinic.
Results: 41 infants were enrolled. GERD was found in 80% of patients (moderate in 54%, severe
in 27%). A normalization of the cardiorespiratory tracks was recorded on average after 1 month
for group A, 7 months for the group B and 9.5 months for group C. A significant difference was
registered between group A and both group B and C (P < 0.0001), as well as between the group
B and C (P < 0.05).
Conclusion: GERD influences significantly the time of normalization of the cardiorespiratory
monitoring in infants with ALTE. GERD diagnosis and treatment are mandatory in these patients.
Copyrightª 2016, TaiwanPediatric Association. Published by Elsevier Taiwan LLC. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).of Pediatric Surgery, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Via Commenda 10,
tmail.it (A. Morandi).
Macchini F, et al., Acid Gastroesophageal Reflux Disease and Apparent Life-Threatening Events:
diorespiratory Monitoring, Pediatrics and Neonatology (2016), http://dx.doi.org/10.1016/
015.12.005
ediatric Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-
ns.org/licenses/by-nc-nd/4.0/).
2 F. Macchini et al
+ MODEL1. Introduction
Apparent life-threatening event (ALTE), previously called
near-miss sudden infant death syndrome (SIDS), is “an
episode that is frightening to the observer and character-
ized by a combination of apnea, color change (cyanosis or
pallor), marked change in muscle tone, choking or
gagging,” according to a National Institute of Health
consensus conference.1 The hypothesis that apnea may
precede SIDS has led to an extensive development of apnea
monitors for domiciliary use.2 Gastroesophageal reflux dis-
ease (GERD) has been considered to play a role in the
pathogenesis of ALTE,3,4 even if previous studies have not
been able to demonstrate this relationship.5,6
The aim of our study was to investigate the prevalence
and the characteristics of GERD in infants with ALTE. In
particular, the focus was on the potential influence of GERD
on the time of normalization of symptoms and monitoring.
2. Methods
From June 2013 to December 2014, all infants with at least
one episode of ALTE and typical symptoms of GERD that
were referred to our Center were considered for the pre-
sent study. After completing a protocol of investigations
(Table 1), patients with severe prematurity (<25 weeks
gestational age), and any kind of infectious or neurological,
cardiac, or metabolic disorders, were excluded.7 A
cardiorespiratory recording was always performed within at
least 2 days from the event for a minimal duration of
48 hours. The recording consisted of an airflow monitoring
by thermistor to diagnose obstructive apnea, and a moni-
toring of the heart rate and chest movements by impedance
and pulse oximeter. The signals were digitalized and
recorded at a rate of four samples per second and down-
loaded onto a personal computer when completed. Tracings
were analyzed using a semiautomated system and reviewed
by a technician. Apneas longer than 16 seconds were
recorded, as well as the occurrence of bradycardia (to
<100 beats/min for >5 seconds) or desaturation (to <85%
for >10 seconds).8,9 Following written informed parental
consent, a simultaneous 24-h pH monitoring was performed
(DIGITRAPPER pH400 Alpine Biomed ApS, Denmark) with a
two-channel probe (Versaflex disposable pH catheter DualTable 1 Protocol of investigation for children with ALTE.
 Recording of anamnesis
 Blood chemistry
 Dosage of serum and urinary amino acids and urinary
organic acids
 Cardiac evaluation with ECG and cardiac US (þ Holter
registration in case of arrythmias)
 Neurological evaluation with EEG and or polysomnography
 Brain MRI
 48 h cardiorespiratory monitoring
 24 h pH-metry
ALTE Z apparent life-threatening event; ECG Z electrocar-
diogram; EEG Z electroencephalogram; MRI Z magnetic reso-
nance imaging; USZ ultrasound.
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the junction of the mid and lower third of the esophagus,
2.5 cm above the lower esophageal sphincter, and the distal
one in the stomach, as confirmed by a chest X-ray.
During recording, infant care was not altered, and breast
milk or formula feedings were continued. None of these
infants had ever received pharmacological therapy for
GERD at the time of the pH-metry.
Gastroesophageal reflux was diagnosed when the
esophageal pH fell below 4.0. Reflux was evaluated by the
number of individual episodes, the length of each episode,
the total duration of reflux, and the percentage of reflux in
the study period [reflux index (RI)].10 RI is usually consid-
ered pathological when it exceeds 4%. In order not to un-
derestimate the reflux, we decided to divide the population
into three groups: group A, which has a normal RI (<3%);
group B, which has a moderate increase in RI (3e7%); and
group C, which has a severe increase in RI (>7%; Table 2).
Furthermore, the evidence of a pathological monitoring
was also determined in the presence of interdigestive epi-
sodes of reflux, including prolonged and/or nocturnal ones,
and according to the symptom index.
Groups B and C were subsequently treated with proton
pump inhibitors (Esomeprazole) at a dosage based on the
child’s weight (1 mg/kg per day).
The follow-up was characterized by monthly clinical
evaluations associated with cardiorespiratory monitoring.
Pharmacological antireflux therapy was prolonged until the
normalization of the monitoring and the resolution of
symptoms. Children were considered cured after two
consecutive monitorings within the normal range. Normal-
ization of the cardiorespiratory monitoring was considered
when there was no evidence of apnea, bradycardia, or
desaturation.
Gestational age at birth, birth weight, and sex were
analyzed as potential risk factors for GERD. Patients were
divided into two groups according to gestational age: pa-
tients born prior to the 30th gestational week and patients
born afterward. Considering birth weight, patients were
divided into very low birth weight (VLBW; <1500 g) and
other than VLBW (>1500 g). The study was granted pre-
liminary approval by our institutional Ethical Committee as
part of the institutional protocol for the management of
GERD (M.04.360).
2.1. Statistical analysis
Normalization time was compared between groups using
one-way analysis of variance followed by Bonferroni
method and linear regression analysis. When considering
potential risk factors, such as birth weight, gestational age,
and sex, statistical analysis was performed with Fisher’s
exact test. A p value <0.05 was considered statistically
significant. StatView software 5.0 was used for the analysis.
3. Results
Fifty infants (28 males, mean age 1.5 months) were
referred to our Center during the study period. Clinical
manifestations of these infants are shown in Figure 1. Based
on the results of the preliminary protocol of investigations,sophageal Reflux Disease and Apparent Life-Threatening Events:
iatrics and Neonatology (2016), http://dx.doi.org/10.1016/







RI (%) Group SI (%) Normalization
of monitoring
(no. of evaluations)
1 1430 M 31 Des 75 15.1 C 33 5
2 1750 M 30 Des þ apn þ cyan 55 5.6 B 43 5
3 2230 F 34 Des þ apn þ cyan 31 6.7 B 50 7
4 1320 F 27 Des þ apn þ cyan 70 11.5 C 87 11
5 1250 F 31 Des 80 1.7 A 25 1
6 2580 M 35 Des þ apn þ cyan 20 5.6 B 55 6
7 1410 M 29 Des þ apn þ cyan 62 13.7 C 67 10
8 3100 M 38 Des 18 4.5 B 28 6
9 2750 F 37 Des 22 5.7 B 43 8
10 2920 F 38 Des 28 3.5 B 33 4
11 1375 M 28 Des 72 6.6 B 67 7
12 3075 M 39 Des þ apn þ cyan 33 7.0 B 73 6
13 2490 M 35 Des þ apn þ cyan 45 8.6 C 60 6
14 1980 F 33 Des 42 0.3 A 33 1
15 1380 M 32 Des þ apn þ cyan 65 2.1 A 10 1
16 3310 F 39 Des þ apn þ cyan 35 5.1 B 55 5
17 1680 M 33 Des 66 4.5 B 60 3
18 1120 M 26 Des þ apn þ cyan 95 14.0 C 50 9
19 2890 M 37 Des þ apn þ cyan 39 6.6 B 67 3
20 3130 M 38 Des 26 9.0 C 80 7
21 2780 F 37 Des 42 4.3 B 62 9
22 2550 F 36 Des þ apn þ cyan 45 5.9 B 43 7
23 1235 F 27 Bradi þ des 69 16.8 C 50 11
24 3020 F 39 Bradi þ des 24 0.2 A 10 1
25 1790 M 34 Des 78 12.8 C 90 8
26 2230 M 35 Des þ apn þ cyan 60 6.7 B 60 5
27 3180 F 39 Des þ apn þ cyan 27 6.9 B 67 10
28 2590 M 36 Des þ apn þ cyan 39 4.0 B 55 2
29 2775 M 37 Des 22 2.5 A 14 1
30 2960 F 37 Des þ apn þ cyan 15 6.5 B 73 6
31 3310 F 40 Des þ apn þ cyan 19 2.9 A 20 1
32. 2480 M 35 Des þ apn þ cyan 40 4.4 B 62 5
33 2660 F 35 Des 44 1.2 A 25 1
34 3150 F 39 Des 28 12.2 C 73 9
35 2820 M 38 Bradi þ des 35 7.0 B 75 7
36 1930 M 33 Des 32 6.8 B 50 8
37 2160 F 34 Des þ apn þ cyan 47 3.7 B 28 4
38 2450 M 36 Des 41 1.0 A 20 d
39 3860 F 39 Other 23 11.2 C 50 5
40 2220 M 35 Des 40 13.8 C 80 7
41 1980 M 34 Des 39 5.5 B 60 9
apn Z apnea; cyan Z cyanoses; des Z desaturation; RI Z reflux index; SI Z symptom index.
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normalities, 2 were cardiopathic, and 2 presented a
metabolic disorder). Therefore, 41 patients were included
in the study. All of them had pathological cardiorespiratory
monitoring. Thirty-three infants (80%) had a pathological
pH-metry. Among them, 22 were included in group B, and
11 in group C.
All patients with GERD were pharmacologically treated
until normalization of the monitoring and resolution of signs
and symptoms were achieved. Subsequently, at follow-up
no further clinical problem was recorded and no further
ALTE episode was registered. Cardiorespiratory evaluations
were performed monthly, at a mean time of 35  5 days. APlease cite this article in press as: Macchini F, et al., Acid Gastroe
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0.9 evaluations (1 month) for group A, six evaluations
(7 months) for group B, and eight evaluations (9.5 months)
for group C. A statistically significant difference was found
in the time of normalization between different groups. In
particular, a significant difference was noticed for both
groups B and C when compared to group A (p < 0.001) as
well as between groups B and C (p < 0.05). Linear regres-
sion analysis is shown in Figure 2.
Considering gestational age, six patients were born prior
to the 30th week (mean 28  1.2). All these patients pre-
sented a pathological pH-metry, and in four out of six pa-
tients (80%) GERD was considered severe. However, insophageal Reflux Disease and Apparent Life-Threatening Events:
iatrics and Neonatology (2016), http://dx.doi.org/10.1016/
Figure 1 Apparent life-threatening event (ALTE): clinical
manifestations.
Figure 2 Linear regression.
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prevalence of GERD (p Z NS).
Eight patients were VLBW (mean weight, 1330  112 g),
six of whom presented GERD, which was severe in five pa-
tients. None of the patients was extremely low birth weight
(<1000 g). Birth weight was not related to the prevalence
of GERD. However, when considering only patients with
GERD, birth weight was related to the severity of the dis-
ease (p Z 0.009). No significant difference was recorded
according to sex.
4. Discussion
ALTEs have been reported to occur in 0.5e10 children per
1000 live births.11 There is significant evidence implicating
GERD as one potential risk factor for ALTE, with a preva-
lence of about 31%.12,13 There are two possible mechanisms
by which GERD is thought to cause ALTE. The first one is a
chemoreflex in the larynx triggered by the presence of
refluxed gastric fluid.14 The second one is the stimulation of
the distal esophagus by the refluxed gastric fluids.15
Desaturation with apnea and cyanosis are the most
common manifestations of ALTE (84%). Previously reported
estimates of the prevalence of GERD in the general pedi-
atric population varied from approximately 2% to 25%
depending on the evaluated symptoms.16 The prevalence of
GERD in children who have symptoms suggestive of an ALTE
was 42% in a previous study,17 rising to 80% in our study.Please cite this article in press as: Macchini F, et al., Acid Gastroe
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problem from the first days of life in the neonatal intensive
care unit and pediatric department, with careful moni-
toring and selection of patients. In fact, the treatment of
reflux, when present, allows a rapid remission of symptoms
and normalization of cardiorespiratory monitoring.
Birth weight seems to play a major role on GERD and its
severity. No significant difference was recorded according
to gestational age and sex. However, larger series may show
different patterns of reflux in patients with different
gestational ages at birth, thus leading to the definition of
different reference ranges for RI according to birth age.
No other studies described the natural history of the
correlation between GERD and ALTE.
On the basis of the reported results, it seems that the
severity of GERD in terms of acid refluxes significantly in-
fluences the time of normalization of the cardiorespiratory
monitoring. Furthermore, from the reported data, the time
of remission seems to be strictly related to the severity of
GERD: the worse the reflux, the longer the time of
normalization of the cardiorespiratory tracks. In support of
these considerations Valusek et al4 suggested performing a
fundoplication in children with GERD associated with
repeated ALTE.
As a consequence, GERD always needs to be ruled out in
the presence of episodes of ALTE in infants without other
predisposing factors. As reported by many authors, pH
monitoring is the most useful test for GERD, as it can be
used over long periods and offers quantitative data.18
Furthermore, it also allows prolonged monitoring with
other physiological recordings in order to detect associ-
ated cardiorespiratory events in “at risk” infants.19
Nevertheless, several technical limitations remain,
related to pH probe monitoring and its efficacy in
detecting the relationship between GERD and apnea. In
particular, many refluxes may be undetected by the pH
probe because of the frequent feedings of the infants,
determining a prolonged elevation of gastric pH. In addi-
tion, nonacid reflux and rerefluxes that occur while the
esophageal pH is still acidic may not be detected. The
intraluminal impedance technique could offer more pre-
cise information about either weakly acidic or weakly
alkaline episodes of reflux and also rerefluxes.6,20 How-
ever, this complex technique still needs validated data
concerning normal and pathological scores, especially in
infants.21,22 Although the measurement of multiple intra-
luminal impedance via the esophageal catheter in addition
to esophageal pH has enhanced our understanding of
GERD, it did not demonstrate a causal relationship be-
tween apnea and GERD. Therefore, we preferred to adopt
only 24-hour pH-metry.235. Conclusion
GERD seems to play a crucial role in the etiopathogenesis
and natural history of ALTE. The severity of GERD influences
the time of normalization of cardiorespiratory monitoring,
and antireflux therapy is helpful in preventing new episodes
of ALTE. Because of its role, we strongly recommend
investigating GERD in infants with ALTE in order to prevent
further dangerous episodes.sophageal Reflux Disease and Apparent Life-Threatening Events:
iatrics and Neonatology (2016), http://dx.doi.org/10.1016/
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